Bank of New York Mellon
IMNM icon

Bank of New York Mellon’s Immunome IMNM Stock Holding History

Bank of New York Mellon’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.33M Buy
298,866
+22,800
+8% +$488K ﹤0.01% 2297
2026
Q1 		$6.04M Buy
276,066
+12,692
+5% +$282K ﹤0.01% 2209
2025
Q4 		$5.66M Buy
263,374
+46,336
+21% +$813K ﹤0.01% 2249
2025
Q3 		$2.54M Buy
217,038
+11,781
+6% +$117K ﹤0.01% 2676
2025
Q2 		$1.91M Buy
205,257
+12,110
+6% +$99.3K ﹤0.01% 2777
2025
Q1 		$1.3M Buy
193,147
+69,944
+57% +$671K ﹤0.01% 2906
2024
Q4 		$1.31M Sell
123,203
-1,736
-1% -$21K ﹤0.01% 2979
2024
Q3 		$1.83M Sell
124,939
-25,161
-17% -$358K ﹤0.01% 2800
2024
Q2 		$1.82M Buy
+150,100
New +$2.35M ﹤0.01% 2845
2024
Q1 		– Sell
-15,844
Closed -$170K – 4236
2023
Q4 		$170K Buy
+15,844
New +$132K ﹤0.01% 3995

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's IMNM Position: Q2 2026 in Review

Bank of New York Mellon increased its Immunome (IMNM) stake by 8.3% in Q2 2026, buying an estimated $488K and bringing the position to 298,866 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

Bank of New York Mellon first reported a position in IMNM in Q4 2023 and has held it in 10 quarters since. 62 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Bank of New York Mellon held 298,866 shares of Immunome worth $6.33M as of Q2 2026.
  • Bank of New York Mellon bought 22,800 Immunome shares in Q2 2026, an estimated $488K.
  • Immunome made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2297 holding.
  • Bank of New York Mellon first reported a position in Immunome in Q4 2023 and has held it in 10 quarters since.
  • 62 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.